Bruce S Stambler, James E Ip. Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial.Cardiology and therapy. 2023, 12 (4): 545-555
Sarah Badger, James McVeigh, Praveen Indraratna. Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines.Cardiology and therapy. 2023, 12 (4): 571-588
Gergely Galos, Eszter Szabados, Miklos Rabai, Rita Szalai, Luca Anna Ferkai, Ildiko Papp, Kalman Toth, Barbara Sandor. Evaluation of Incidence and Risk Factors of Sudden Cardiac Death in Patients with Chronic Coronary Syndrome Attending Physical Training.Cardiology and therapy. 2023, 12 (4): 689-701
Milan Gupta, Rajvi J Wani, Khalid Al Faraidy, Jean Bergeron, Eduardo Contreras, Angel Alberto Garcia Peña, G B John Mancini, Francisco Padilla, Abel Alberto Pavia Lopez, Kiran Philip, Johnny Wu, Erin S Mackinnon. Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.Cardiology and therapy. 2023, 12 (4): 703-722
Masahiro Yasaka, Hiroyuki Yokota, Michiyasu Suzuki, Hidesaku Asakura, Teiichi Yamane, Yukako Ogi, Takaaki Kimoto, Daisuke Nakayama. Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study.Cardiology and therapy. 2023, 12 (4): 723-740
Asher Gorantla, Mahmoud Alsaiqali, Jonathan Francois, Shruthi Sivakumar, Leonell Freytes-Santiago, Ahmad Jallad, Adam S Budzikowski. Comparative Effectiveness of Various Radiofrequency Ablation Catheters in the Ablation of Typical Atrial Flutter.Cardiology and therapy. 2023, 12 (4): 741-747
Miki Imura, Jun Katada, Taro Shiga. Correction to: Epidemiological Study Regarding the Incidence of Venous Thromboembolism in Patients After Cancer Remission.Cardiology and therapy. 2023, 12 (4): 749
Jamshed Dalal, Praveen Chandra, Saumitra Ray, P K Hazra, Jagdish Hiremath, Viveka Kumar, Mahesh K Shah, Jabir Abdullakutty, Debasis Ghosh, Karthik Vasudevan, Panchanan Sahoo. Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists.Cardiology and therapy. 2023, 12 (3): 445-471